Amphastar Pharmaceuticals (AMPH) Operating Leases (2019 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Operating Leases of $75.1 million for Q1 2026, up 84.59% year-over-year from $40.7 million in Q1 2025, and up 99.39% quarter-over-quarter from $37.7 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Operating Leases (2019 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $75.1 million for Q1 2026.
- In Q1 2026, Operating Leases rose 84.59% year-over-year to $75.1 million; the TTM figure through Mar 2026 stood at $75.1 million (up 84.59% YoY), while the FY2025 annual figure was $37.7 million, down 10.02% from the prior year.
- Operating Leases for Q1 2026 stood at $75.1 million, up from $37.7 million in the prior quarter.
- The five-year high for Operating Leases was $75.1 million in Q1 2026, with the low at $23.7 million in Q4 2022.
- The 5-year median for Operating Leases is $29.5 million (2024), against an average of $33.4 million.
- The sharpest annual moves came in 2025 and 2026: Operating Leases slipped 10.02% in 2025, then surged 84.59% in 2026.
- Amphastar Pharmaceuticals' Operating Leases stood at $23.7 million in 2022, then gained by 25.44% to $29.7 million in 2023, then soared by 40.91% to $41.9 million in 2024, then declined by 10.02% to $37.7 million in 2025, then surged by 99.39% to $75.1 million in 2026.
- Business Quant data shows AMPH's Operating Leases at $75.1 million in Q1 2026, $37.7 million in Q4 2025, and $39.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.47 Mn |
| Mar 31, 2026 | 75.14 Mn |
| Dec 31, 2025 | 37.68 Mn |
| Sep 30, 2025 | 39.44 Mn |
| Jun 30, 2025 | 38.96 Mn |
| Mar 31, 2025 | 40.71 Mn |
| Dec 31, 2024 | 41.88 Mn |
| Sep 30, 2024 | 28.94 Mn |
| Jun 30, 2024 | 29.48 Mn |
| Mar 31, 2024 | 28.74 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Sep 30, 2023 | 30.20 Mn |
| Jun 30, 2023 | 24.41 Mn |
| Mar 31, 2023 | 23.99 Mn |
| Dec 31, 2022 | 23.69 Mn |
| Sep 30, 2022 | 24.37 Mn |
| Jun 30, 2022 | 24.68 Mn |
| Mar 31, 2022 | 25.49 Mn |
| Dec 31, 2021 | 24.70 Mn |
| Sep 30, 2021 | 25.47 Mn |